INTRODUCTION
Liver disorders complicate up to 3 % of all pregnancies. 1 It could be peculiar to pregnancy like hyperemesis gravidarum, acute fatty liver of pregnancy, cholestasis of pregnancy, hemolysis, elevated liver enzymes, and a low platelet count (HELLP) syndrome and jaundice complicating hypertensive disorders of pregnancy. These conditions usually remit spontaneously in the puerperium. It can be unrelated to pregnancy in patients of infective causes like viral hepatitis and malaria, gall stones, certain drugs or pregnancy in patients of chronic liver diseases. Abnormal liver function tests may be found in 3-5% of pregnancies with many potential causes including coincidental liver disease and underlying chronic liver disease. 1 Incidence of jaundice in pregnancy varies greatly worldwide. In developed countries the incidence is around 0.1% whilst in developing countries it can be range from 3-20% or higher.
prognosis for both fetus and mother. It is responsible for about 60% of perinatal mortality and 14% of maternal mortality. 3 Viral hepatitis is the most common cause of jaundice during pregnancy. 4 The course of most viral hepatitis infections (e.g., hepatitis A, B, C and D) is unaltered by pregnancy. However, a more severe course of viral hepatitis in pregnancy has been noted in patients with hepatitis E and disseminated herpes simplex virus (HSV) infections. 5, 6 Hepatitis E, usually a benign hepatitis infection in men and non pregnant women, acquires a grave form in pregnant women. The incidence of fulminant hepatic failure and mortality rate is much higher than that associated with other hepatic viral infections. 7 It is the most common hepatotrophic virus associated with fulminant hepatic failure (FHF). 8 Approximately, 30% cases of HEV may manifest as FHF with mean maternal mortality of 21.4%, highest being reported from the developing countries. [9] [10] [11] Jaundice in pregnancy appears to be most common in the third trimester. This could be directly attributable to the impairment of the liver to excrete the conjugated bilirubin in the third trimester. 12 Jaundice is associated with increased fetal morbidity and mortality, particularly from chrionic placental insufficiency, preterm labour fetal distress and intrauterine fetal demise. 13 An understanding of disease complications can help to formulate effective strategies for disease prevention, control and patients management leading to better fetomaternal outcome. People have moderate knowledge on jaundice, especially very low knowledge over complications and types of jaundice, which has to be improved through adequate education from antenatal period itself.
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METHODS
The prospective observational study on 122 antenatal cases with jaundice admitted at Department of obstetrics and gynecology, King George's Medical University, Lucknow from over a period of one year (August 2016 to July 2017) after getting approval of ethical clearance.
The aim of the study was to know about incidence of jaundice at our hospital, and its effect on fetomaternal outcome. In this study total 122 cases were enrolled after informed consent.
Inclusion criteria
• All antenatal women booked or unbooked presenting with clinical or laboratory evidence of jaundice • Patients giving consent.
Exclusion criteria
• Patient not giving consent A detailed history of patients illness including origin, duration and progress of following symptoms like yellow coloured urine, anorexia, nausea, vomiting, fever, epigastric pain and pain in abdomen, constipation /diarrhoea, irritability, weakness. Thorough general, systemic and obstetrical examination was done.
Every patient was investigated by routine CBC and PBF for haemoglobin, total and different WBC count, platelet counts, blood group, TSH, Blood sugar, Blood urea, HIV, VDRL, malaria. Urine examination was carried out for presence of albumin, sugar, bile salts, bile pigments, urobilinogen and microscopical abnormalities, LFT including SGOT, SGPT, alkaline phosphatase, Prothombin time (PT), partial thromboplastin time (PTT), BT and CT were done Serological tests for viral markersIgManti-HAV antibody, HBV (HBsAg, HbeAg, IgM anti HBV core antigen), IgM anti-HCV antibody and IgM anti-HEV antibody were done.
Statistical analysis
The results are presented in frequencies, percentages and mean±SD. The Chi-square test was used to find the association between categorical variables. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy Swede score was calculated in predicting the HPV. The p-value <0.05 was considered significant. All the analysis was carried out on SPSS 16.0 version (Chicago,Inc., USA).
RESULTS
A total of 122 antenatal women with jaundice were included in the study giving an incidence of 12 cases /1000 deliveries (1.2%). Majority of patients were of age group 20-25 years (48.4%) ( Table 1) . Maximum cases were found to be unbooked (73.8%), and of low socioeconomic status (50.81%). In this study incidence of jaundice in pregnancy were highest in multigravida i.e. 52%. Most of 69.7 % cases had gestational age between 29-40 weeks (69.7%) followed by 14-28 weeks (27.9%) and 0-13 (2.5%) weeks ( Figure 1 ). Majority of cases were seen in 3 rd trimester of pregnancy. 
Causes of jaundice in pregnancy
Preeclampsia was the most common cause (50.0%) followed by Cholestatsis of pregnancy (23.75), Hepatitis (17.2%) and Acute fatty liver disease (9.1%) ( Figure 2 ). Out of total 122 cases, 16.4% cases of preeclampsia had HELLP syndrome. In our study HBV is the most common cause of acute hepatitis comprises 47.6% HEV was positive in 28.6%% of cases. However, HCV and HAV were positive in 14.3% and 9.5% of cases respectively ( Table 2) . 35.3% case show bilirubin level less than 10mg/dl and 64.7% showed bilirubin more than 10 mg/dl.
According to LFT, more than half of cases had SGOT 100-500 (59%) followed by <100 (24.6%) and >1000 (9.8%) and 501-1000 (6.6%). However, SGPT was 100-500 among 52.5% cases and <100 in 23% of cases. ALP was between 100-500 among about half of the cases (49.1%) ( Table 3 ). PT and INR were abnormal in 45.9% cases. 
Cause of death
Total hospital maternal mortality was 39.3%. Hepatic encephalopathy was the main reason for death (64.6%) followed by MODS (10.4%), HELLP + DIC (10.4%), PPH (8.3%) and least is septicemia (6.3%) (Figure 3 ). On comparison of maternal mortality with causes of jaundice, the percentage of mortality was higher in hepatitis cases (47.6%) and was least in preeclampsia cases (19.5%). (Table 5 ) On comparison of maternal mortality with total bilirubin, the percentage of maternal mortality was higher among those who had total bilirubin 10-15 (59.7%). It was observed thatthe percentage of mortality was 16.7% when SGOT was >1000 while there was no mortality when SGOT was < 1000, the percentage of mortality was higher among those who had SGPT >1000 (57.1%) than 501-1000 (22.2%). Also the percentage of mortality was higher among those who had ALP levels>1000 (73.3%) ( Table 6 ). 
Perinatal outcome
In this study we observed that out of 73 delivered cases -63% babies were health yet the time of discharge, 27.4% were stillborn and 9.6% had early neonatal death (Table  7) . Total perinatal mortality 37%. NNU and NICU admission was in 56.3% and 43.8% respectively.
DISCUSSION
Jaundice in pregnancy carries a grave prognosis for both fetus and mother. A total of 122 antenatal women with jaundice were included in the study. Incidence-12 cases/1000 deliveries (1.2%). Comparable results were reported for incidence of jaundice in pregnancy. In this study, it was found that the incidence of jaundice in pregnancy was highest in cases of age group 20-25 years (48.4%). It may be due the fact that higher number of pregnancies were in this age group. Comparable to the results as cited by Nagaria T et al, who observed maximum incidence of jaundice in 20-30 years that is 89.02%, Karegoudar D et al, found that maximum incidence of jaundice in patients of age group 21-30 years that is 75.68%. 3, 19 However, Reddy MG et al, found that maximum incidence of jaundice in pregnancy in age group 15-20 years that is 50%. 20 In our study, majority of the cases were unbooked (73.8%) and had their first antenatal visit during labour. This is due to lack of awareness about antenatal checkups, low socioeconomic status and poor accessibility to health care centre. Similar results were cited by Nagaria T et al, (80.55%) Karegoudar D et al, (56.76%) and Singh K et al, (75.14%) cases. 3, 19, 21 In this study incidence of jaundice in pregnancy was highest in multigravida i.e., 52%. Mitta P et al, also noted that majority of causes were multigravida 61.9%. 22 Conversely, Singh K et al, and Sharma S et al, noted that 66.6% of cases were primigravida. 21, 23 In our study, more than half of cases had gestational age between 29-40 weeks (69.7%). Majority of case were seen in 3rd trimester of pregnancy because majority of liver disease which are unique to pregnancy develop in between 34-37 weeks of the gestation. Similar findings were observed by Nagaria T et al, 95% cases, Reddy MG et al, 80.39% casesand Mitta P et al, 83.33% cases.
3,20,22 Sharma R et al, observed all cases were in 3 rd trimester. 23 In our study most common cause of jaundice was preeclampsia, this may be due the fact that, incidence of preeclampsia is more at our hospital, but the rise in bilirubin was not so high in these cases( bilirubin level< 10 mg%), therefore the outcome was better in these cases. Similar observations were observed by Choudhary N et al, according to which preeclampsia and HELLP syndrome were observed in 46.55% cases. 24 In our study HBV was the most common cause of acute hepatitis comprising 47.6% and HEV was positive in 28.6% of cases.
According to LFT more than half of cases had SGOT 100-500 (59%), SGPT was 100-500 among 52.5% cases, ALP was between 100-500 among about half of the cases (49.1%). High levels of SGPT, SGOT, were associated with viral hepatitis and had poor outcome leading to increase in maternal mortality. Mitta P et al, also found that high level of S. Bilirubin, SGPT and SGOT levels more than 500 IU/ml were associated with viral hepatitis. In our study, 64.7% showed bilirubin more than 10mg/dl. Higher the bilirubin values, poorer was the outcome. Due to this fact we had higher number of morbidity and mortality. Reddy MG et al, observed S. bilirubin level more than 10mg/dl present in 44.4% cases. 22 Conversely, Karegoudar et al, observed that 67.5% of cases had bilirubin level less than 10mg/dl, this variation in observation of other studies could be due to difference in etiological and geographical distribution. 19 In our study among 122 cases 73 were delivered and 49 were undelivered. LSCS were (32) 43.9% and vaginal deliveries were (41) 56.1%. Nagaria T et al, have reported vaginal delivery in 58% and cesarean section was done in 28%. 3 Patel BJ et al, observed that 91.8% patient delivered, out of which 82.2% delivered vaginally while 17.7% were delivered by LSCS.
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Maternal outcome
In our study, hepatic encephalopathy was the main reason for maternal death (64.6%) followed by MODS (10.4%), HELLP+DIC (10.4%), PPH (8.3%) and septicemia (6.3%). Singh et al, in their study also found that hepatic encephalopathy was the commonest cause (33.33%) followed by DIC (25%) and sepsis (25%). 21 While in other researches various other reasons were predominantly seen like, Satia MN et al, noted that the incidence of DIC (44%) was high in their study followed by postpartum hemorrhage (22%) and hepatic encephalopathy (20%) Reddy MG et al, noted that maternal mortality was most common in women with acute fatty liver of pregnancy and HELLP syndrome. 20, 25 Mitta P et al, noted that the common maternal complications were DIC 11.9%, renal failure 7.14%, abruption, atonic PPH were 4.76%. 22 The percentage of mortality was higher in hepatitis cases (80%) and was least in preeclampsia cases (19.5%).
The percentage of mortality was 16.7% among whom SGOT was >1000, 57.1% with SGPT >1000, 73.3% ALP >1000, 59.7%with total bilirubin10-15mg%.
According to neonatal outcome we observed that out of 73 delivered cases 63% babies were discharged healthy, 27.4% were stillborn and 9.6% had early neonatal death. Total perinatal mortality was 37%. Higher perinatal mortality was also reported by Nagaria T et al, 61.76% with 50% stillbirth and 11.76% early neonatal death. 3 Perinatal mortality as cited by Acharya N et al was 16 .6%, Karegoudar D et al, 46.16%, Jayanthi et al 19% and Mitta P et al 30.76%. 15, 18, 19, 22 Reddy MG et al, reported perinatal mortality of 33.3%. 22 Jayanti K et al reported that perinatal mortality was 35.5% of these 80% was due to prematurity. 18 So, we can say that our perinatal mortality was less, due to early intervention in form of abdominal deliveries.
Our NNU and NICU admissions were in 56.3% and 43.8% respectively Karegoudar D et al, observed that 13.51% required NICU admission. 19 Jayanthi et al, observed that 66.6% babies required NICU admission with low birth weight and meconium aspiration syndrome being the most common indications. 18 Emergence of new contributing factors and constant researches with expanding medical knowledge have a scope for better management and in reducing the morbidity and mortality in mother as well as fetus. Previous research findings did not explore much about epidemiological studies in relation of jaundice with pregnancy from Indian subcontinent.
Therefore, authors planned to execute this study to assess the incidence of jaundice in pregnancy and its effect on fetomaternal outcome.
CONCLUSION
Though jaundice affects a small percentage of pregnant women, it carries very poor maternal and fetal outcome. Poor outcome may be attributed to delay in seeking medical advice, lack of awareness, low socioeconomic status, lack of proper antenatal checkups leading to delay in early diagnosis and management, delay in referral to the hospital. 100% ANC booking, routine antenatal screening for hepatitis B and proper regular checkups can reduce the burden of this disease and can help reducing feto-maternal morbidity and mortality. A female admitted with jaundice must be considered high risk and timely management must be given by a trained group of doctors (multidisciplinary approach) Timely referral and transport facilities, adequately trained medical and paramedical staff, availability of blood banks and ventilatory support, good NICU set up can improve the maternal and fetal outcome.
